• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refractory acquired thrombotic thrombocytopenic purpura treated with caplacizumab in a pediatric patient with systemic lupus erythematosus.

作者信息

Nagel Margaret B, Ryder Alex, Lobbins Monica, Bhatt Nidhi

机构信息

St Jude Children's Research Hospital, Memphis, Tennessee.

West Cancer Center and Research Institute, Memphis, Tennessee.

出版信息

Pediatr Blood Cancer. 2021 Jan;68(1):e28534. doi: 10.1002/pbc.28534. Epub 2020 Jul 13.

DOI:10.1002/pbc.28534
PMID:32658352
Abstract
摘要

相似文献

1
Refractory acquired thrombotic thrombocytopenic purpura treated with caplacizumab in a pediatric patient with systemic lupus erythematosus.在一名患有系统性红斑狼疮的儿科患者中，用卡泊珠单抗治疗难治性获得性血栓性血小板减少性紫癜。
Pediatr Blood Cancer. 2021 Jan;68(1):e28534. doi: 10.1002/pbc.28534. Epub 2020 Jul 13.
2
Successful use of caplacizumab in a case of refractory acquired thrombotic thrombocytopenic purpura following subacute thyroiditis.成功使用卡普拉西珠单抗治疗亚急性甲状腺炎后难治性获得性血栓性血小板减少性紫癜。
Transfus Apher Sci. 2021 Feb;60(1):103010. doi: 10.1016/j.transci.2020.103010. Epub 2020 Nov 7.
3
Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab.一名青少年接种BNT162b2疫苗后出现血栓性血小板减少性紫癜，使用卡泊单抗成功治疗。
Br J Haematol. 2022 Jan;196(1):e11-e14. doi: 10.1111/bjh.17782. Epub 2021 Aug 17.
4
Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura.卡普拉珠单抗在获得性血栓性血小板减少性紫癜治疗中的作用。
J Oncol Pharm Pract. 2020 Oct;26(7):1695-1702. doi: 10.1177/1078155220934862. Epub 2020 Jun 30.
5
Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.利妥昔单抗治疗难治性血栓性血小板减少性紫癜及系统性红斑狼疮中自身免疫介导的血小板减少症
South Med J. 2008 Sep;101(9):943-4. doi: 10.1097/SMJ.0b013e3181809ebd.
6
NICE guidance on caplacizumab for treating acute acquired thrombotic thrombocytopenia purpura.英国国家卫生与临床优化研究所关于卡泊单抗治疗急性获得性血栓性血小板减少性紫癜的指南。
Lancet Haematol. 2021 Jan;8(1):e14-e15. doi: 10.1016/S2352-3026(20)30406-3.
7
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.卡泊西单抗用于获得性血栓性血小板减少性紫癜
N Engl J Med. 2016 Jun 23;374(25):2497-8. doi: 10.1056/NEJMc1603180.
8
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.卡泊西单抗治疗获得性血栓性血小板减少性紫癜
N Engl J Med. 2016 Jun 23;374(25):2497. doi: 10.1056/NEJMc1603180.
9
Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial).卡泊珠单抗治疗获得性血栓性血小板减少性紫癜（大力神试验）。
Transfus Med. 2019 Jun;29(3):146-148. doi: 10.1111/tme.12615.
10
Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab.镰状细胞 trait 患者伴发难治性获得性血栓性血小板减少性紫癜，使用 caplacizumab 成功治疗。
Hematology. 2021 Dec;26(1):590-593. doi: 10.1080/16078454.2021.1959984.

引用本文的文献

1
The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review.极端年龄下血栓性血小板减少性紫癜的特点：一项叙述性综述
J Clin Med. 2023 Apr 23;12(9):3068. doi: 10.3390/jcm12093068.
2
The Efficacy and Safety of Plasma Exchange in the Treatment of Thrombotic Thrombocytopenic Purpura.血浆置换治疗血栓性血小板减少性紫癜的疗效和安全性。
J Healthc Eng. 2022 Mar 31;2022:3519937. doi: 10.1155/2022/3519937. eCollection 2022.
3
Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura.
基于模型的卡普西珠单抗剂量推荐用于儿童获得性血栓性血小板减少性紫癜。
J Clin Pharmacol. 2022 Mar;62(3):409-421. doi: 10.1002/jcph.1991. Epub 2021 Nov 29.
4
Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab.一名青少年接种BNT162b2疫苗后出现血栓性血小板减少性紫癜，使用卡泊单抗成功治疗。
Br J Haematol. 2022 Jan;196(1):e11-e14. doi: 10.1111/bjh.17782. Epub 2021 Aug 17.